May 21 2024University of Basel
The immunologists working with De Libero discovered the immune cells in question, known as MR1T cells, around ten years ago. This previously unknown type of T cell can attack and eliminate tumor cells. Since then, the team has been researching these cells as a potential tool for novel immunotherapies against a variety of different types of cancer.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How immune cells recognize the abnormal metabolism of cancer cellsWhen cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel have now demonstrated that this change leaves traces that could provide targets for cancer immunotherapies.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers develop new technique for breath analysis to monitor young patient health statusResearchers are using breath analysis to monitor patients' health status in real time and check levels of certain medicines. Scientists from the University of Basel and University Children's Hospital Basel (UKBB) have developed a technique that enables them to measure certain parameters from the breath exhaled by their young patients.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers outline how cells activate to cause fibrosis and organ scarringNew research led by Unity Health Toronto that examines how fibroblast cells in the body are activated to cause fibrosis and organ scarring has been published in Nature Reviews Molecular Cell Biology. Fibrosis and organ scarring are leading causes of death, with data suggesting they are responsible for up to 45% of deaths in the developed world.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers enhance CAR-T cells to target solid tumorsResearchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors-;an advance that could transform cancer treatment.
Source: NewsMedical - 🏆 19. / 71 Read more »